Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2013 (2013), Article ID 430459, 10 pages
http://dx.doi.org/10.1155/2013/430459
Research Article

Fabrication of Heparinized Mesoporous Silica Nanoparticles as Multifunctional Drug Carriers

The First Affiliated Hospital, Xinxiang Medical University, Xinxiang 453100, China

Received 28 January 2013; Accepted 1 March 2013

Academic Editor: Yufang Zhu

Copyright © 2013 Yongxiang Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kim, J. E. Lee, J. Lee et al., “Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals,” Journal of the American Chemical Society, vol. 128, no. 3, pp. 688–689, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Chen, H. Chen, S. Zhang et al., “Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs,” Advanced Functional Materials, vol. 21, no. 2, pp. 270–278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Kim, H. S. Kim, N. Lee et al., “Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery,” Angewandte Chemie International Edition, vol. 47, no. 44, pp. 8438–8441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Gai, P. Yang, C. Li et al., “Synthesis of magnetic, up-conversion luminescent, and mesoporous core-shell-structured nanocomposites as drug carriers,” Advanced Functional Materials, vol. 20, no. 7, pp. 1166–1172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Kim, J. E. Lee, J. Lee et al., “Generalized fabrication of multifunctional nanoparticle assemblies on silica spheres,” Angewandte Chemie International Edition, vol. 45, no. 29, pp. 4789–4793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Kumar, I. Roy, T. Y. Ohulchanskyy et al., “Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging,” ACS Nano, vol. 2, no. 3, pp. 449–456, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Sadasivan, D. Khushalani, and S. Mann, “Synthesis and shape modification of organo-functionalised silica nanoparticles with ordered mesostructured interiors,” Journal of Materials Chemistry, vol. 13, no. 5, pp. 1023–1029, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. R. P. Bagwe, L. R. Hilliard, and W. Tan, “Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding,” Langmuir, vol. 22, no. 9, pp. 4357–4362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Huo, J. Liu, L. Q. Wang, Y. Jiang, T. N. Lambert, and E. Fang, “A new class of silica cross-linked micellar core-shell nanoparticles,” Journal of the American Chemical Society, vol. 128, no. 19, pp. 6447–6453, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Jo and K. Park, “Surface modification using silanated poly(ethylene glycol)s,” Biomaterials, vol. 21, no. 6, pp. 605–616, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Y. Yang, S. J. Cai, H. Liu, and C. Pidgeon, “Immobilized artificial membranes—screens for drug membrane interactions,” Advanced Drug Delivery Reviews, vol. 23, no. 1–3, pp. 229–256, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Liu, A. Stace-Naughton, X. Jiang, and C. J. Brinker, “Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles,” Journal of the American Chemical Society, vol. 131, no. 4, pp. 1354–1355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. S. Wang, L. C. Wu, S. Y. Lu et al., “Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding,” ACS Nano, vol. 4, no. 8, pp. 4371–4379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Y. Lai, B. G. Trewyn, D. M. Jeftinija et al., “A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules,” Journal of the American Chemical Society, vol. 125, no. 15, pp. 4451–4459, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Torney, B. G. Trewyn, V. S. Y. Lin, and K. Wang, “Mesoporous silica nanoparticles deliver DNA and chemicals into plants,” Nature Nanotechnology, vol. 2, no. 5, pp. 295–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Giri, B. G. Trewyn, M. P. Stellmaker, and V. S. Y. Lin, “Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles,” Angewandte Chemie International Edition, vol. 44, no. 32, pp. 5038–5044, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. D. R. Radu, C. Y. Lai, K. Jeftinija, E. W. Rowe, S. Jeftinija, and V. S. Y. Lin, “A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent,” Journal of the American Chemical Society, vol. 126, no. 41, pp. 13216–13217, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. C. P. Tsai, C. Y. Chen, Y. Hung, F. H. Chang, and C. Y. Mou, “Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells,” Journal of Materials Chemistry, vol. 19, no. 32, pp. 5737–5743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Rosenholm, A. Meinander, E. Peuhu et al., “Targeting of porous hybrid silica nanoparticles to cancer cells,” ACS Nano, vol. 3, no. 1, pp. 197–206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. Kemp and R. J. Linhardt, “Heparin-based nanoparticles,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 2, no. 1, pp. 77–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ishihara and K. Ono, “Structure and function of heparin and heparan sulfate; Heparinoid library and modification of FGF-activities,” Trends in Glycoscience and Glycotechnology, vol. 10, no. 52, pp. 223–233, 1998. View at Google Scholar · View at Scopus
  22. H. P. T. Ekre, B. Fjellner, and O. Hagermark, “Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions,” International Journal of Immunopharmacology, vol. 8, no. 3, pp. 277–286, 1986. View at Google Scholar · View at Scopus
  23. M. D. Sharath, Z. M. Merchant, and Y. S. Kim, “Small heparin fragments regulate the amplification pathway of complement,” Immunopharmacology, vol. 9, no. 2, pp. 73–80, 1985. View at Google Scholar · View at Scopus
  24. J. M. Weiler, R. E. Edens, R. J. Linhardt, and D. P. Kapelanski, “Heparin and modified heparin inhibit complement activation in vivo,” Journal of Immunology, vol. 148, no. 10, pp. 3210–3215, 1992. View at Google Scholar · View at Scopus
  25. S. M. Smorenburg and C. J. F. Van Noorden, “The complex effects of heparins on cancer progression and metastasis in experimental studies,” Pharmacological Reviews, vol. 53, no. 1, pp. 93–105, 2001. View at Google Scholar · View at Scopus
  26. C. J. van Oss, “Phagocytosis as a surface phenomenon,” Annual Review of Microbiology, vol. 32, pp. 19–39, 1978. View at Google Scholar · View at Scopus
  27. S. C. Wuang, K. G. Neoh, E. T. Kang, D. W. Pack, and D. E. Leckband, “Heparinized magnetic nanoparticles: in-vitro assessment for biomedical applications,” Advanced Functional Materials, vol. 16, no. 13, pp. 1723–1730, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Park, G. Y. Lee, Y. S. Kim et al., “Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity,” Journal of Controlled Release, vol. 114, no. 3, pp. 300–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Deng, X. Li, Q. Peng, X. Wang, J. Chen, and Y. Li, “Monodisperse magnetic single-crystal ferrite microspheres,” Angewandte Chemie International Edition, vol. 44, no. 18, pp. 2782–2785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Guo, Y. Deng, D. Gu, R. Che, and D. Zhao, “Synthesis and microwave absorption of uniform hematite nanoparticles and their core-shell mesoporous silica nanocomposites,” Journal of Materials Chemistry, vol. 19, no. 37, pp. 6706–6712, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Möller, J. Kobler, and T. Bein, “Colloidal suspensions of nanometer-sized mesoporous silica,” Advanced Functional Materials, vol. 17, no. 4, pp. 605–612, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. J. Chung, H. K. Kim, J. J. Yoon, and T. G. Park, “Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery,” Pharmaceutical Research, vol. 23, no. 8, pp. 1835–1841, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Van Speybroeck, V. Barillaro, T. D. Thi et al., “Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs,” Journal of Pharmaceutical Sciences, vol. 98, no. 8, pp. 2648–2658, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Sinha, G. J. Kim, S. Nie, and D. M. Shin, “Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery,” Molecular Cancer Therapeutics, vol. 5, no. 8, pp. 1909–1917, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. A. Bhirde, V. Patel, J. Gavard et al., “Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery,” ACS Nano, vol. 3, no. 2, pp. 307–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Cai, N. Qiu, X. Li et al., “A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells,” International Journal of Pharmaceutics, vol. 408, no. 1-2, pp. 173–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Furukawa, T. Ishiwata, K. Sugikawa, K. Kokado, and K. Sada, “Nano- and microsized cubic gel particles from cyclodextrin metal-organic frameworks,” Angewandte Chemie International Edition, vol. 51, no. 42, pp. 10566–10569, 2012. View at Publisher · View at Google Scholar
  38. M. Vallet-Regí, F. Balas, and D. Arcos, “Mesoporous materials for drug delivery,” Angewandte Chemie International Edition, vol. 46, no. 40, pp. 7548–7558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Bringas, Ö. Köysüren, D. V. Quach et al., “Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field,” Chemical Communications, vol. 48, no. 45, pp. 5647–5649, 2012. View at Publisher · View at Google Scholar
  40. E. Climent, R. Martínez-Máñez, F. Sancenón et al., “Controlled delivery using oligonucleotide-capped mesoporous silica nanoparticles,” Angewandte Chemie International Edition, vol. 49, no. 40, pp. 7281–7283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Aznar, M. D. Marcos, R. Martínez-Máñez et al., “pH- and photo-switched release of guest molecules from mesoporous silica supports,” Journal of the American Chemical Society, vol. 131, no. 19, pp. 6833–6843, 2009. View at Publisher · View at Google Scholar · View at Scopus